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Adolescent depression and the treatment gap
Adolescence is an important risk period for the development of depression, when rates of major depressive disorder (MDD) and symptoms rise markedly. 1 Depressive symptoms and disorder are common in adolescence and are associated with poor long-term mental health, social and educational outcomes. Adolescent MDD is often unrecognised and untreated despite evidence that duration of untreated depressive illness is a key factor in predicting recurrence in adult life. 2 A paper in this issue of Lancet Psychiatry demonstrates the beneficial effect of mental health service contact during adolescence on subsequent depressive symptomatology. 3 In a longitudinal community study, Neufeld and colleagues show that, among 14-year old adolescents with a DSM-IV psychiatric disorder, use of mental health services substantially reduces depressive symptomatology at 36 month follow-up.
Thus, by age 17, the odds of adolescents who had a disorder but without mental health service use reporting depressive symptoms in the clinical range was seven times higher than in adolescents who did access services. Importantly, these findings were generated using statistical methods that balance confounders across intervention and control groups (akin to what is done in randomised controlled trials).
Depression has a complex multifactorial aetiology involving both familial/genetic and social risk factors and there are multiple routes to depression. 1 Clinical symptoms or disorders may also act as precursors for depression. For instance, low mood, anxiety, oppositional behavior and ADHD have all individually been found to precede depression. 4, 5 In the study by Neufeld and colleagues, mental health service contact resulted in improvement in depression symptoms in a group with a range of diagnoses. This is interesting and raises the question of how long-term beneficial effects on depressive symptoms came about for a seemingly disparate group of individuals. It would be informative to see if the beneficial effect on depressive symptoms was driven by a particular diagnostic group. Clearly, it was beyond the scope of the present paper to assess the mechanisms involved in how symptoms were reduced. Nonetheless, it may be worthwhile to speculate about potential mechanisms to help identify the 'active ingredients' of treatment effects. 6 These may differ depending on whether depressive symptoms are the primary or secondary presenting complaint. Interpersonal stress and relationships (with family, peers and teachers), selfrepresentations and engagement in enjoyable activities are all thought to be important in the development of depressive symptomatology and functioning in these areas may also be affected by a range of disorders. For example, oppositional and neurodevelopmental problems may lead to profound social and academic failures, affecting self-representations, interpersonal relationships and vulnerability to depression. 7 Effectively treating a range of psychiatric difficulties could potentially result in an amelioration in depressive symptoms over time. 8 The pathways involved in the long-term beneficial effects on depressive In conclusion, this paper is important in empirically demonstrating the long-term beneficial effects of prompt treatment of adolescent mental health problems and provides hope that this could be achieved with interventions of relatively short duration.
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